Team-Based Care for HIV (ARTAS Trial)

N/A

Recruiting

Research Sponsored by Loma Linda University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 90 days post-study enrollment hospitalization discharge

Awards & highlights

No Placebo-Only Group

Summary

This trial studied how team-based care affects HIV patients' ability to link to follow-up care and hospital readmission rates.

Who is the study for?

This trial is for adults over 18 who are newly diagnosed with HIV, or those known to have HIV but haven't started antiretroviral therapy (ART) within the last month. It's also open to patients not virally suppressed or those without specialist care in the past 6 months. People actively on ART, virally suppressed, and under recent specialist care can't join.

What is being tested?

The study compares a team-based approach called ARTAS for managing HIV in a hospital setting against the usual standard of care. The goal is to see if this method improves patient follow-up treatment and reduces readmissions.

What are the potential side effects?

Since this trial focuses on intervention methods rather than medications, side effects aren't typical as with drug trials. However, there may be indirect effects related to changes in care management that will be monitored.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 90 days post-study enrollment hospitalization discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 90 days post-study enrollment hospitalization discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 90 days post-study enrollment hospitalization discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Rate of linkage to HIV care post discharge

Secondary study objectives

Readmission Rate after initial post-study hospitalization

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: Standard of Care Historic ControlActive Control1 Intervention

Control group will get treatment as usual, which consists of medical care by primary admitting service

Group II: Team based inpatient ARTASActive Control1 Intervention

Eligible patients after the study consent process will receive Antiretroviral Treatment Access Study (ARTAS) intervention by social-worker and a medical consultation by an infectious disease physician

Do I qualify?Apply below to find out